v2.3.0.15
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES  
Net earnings$ 514,261$ 302,001
Adjustments to reconcile net earnings to cash provided by operating activities:  
Depreciation of fixed assets148,042139,229
Amortization of intangibles2,170934
Restricted stock and stock option amortization28,55134,694
Deferred compensation trust22,313(12,284)
Deferred compensation obligation(24,948)13,374
Deferred taxes(9,211)(24,195)
Stock plans tax benefit(12,319)(606)
Retirement plan accrual, net of contributions(12,130)19,554
Changes in operating assets and liabilities26,220(286,956)
Equity in (earnings) of investees, net of dividends18,77318,272
Other items9,4576,399
Cash provided by operating activities711,179210,416
CASH FLOWS FROM INVESTING ACTIVITIES  
Purchases of marketable securities(558,009)(709,439)
Proceeds from the sales and maturities of marketable securities653,2351,124,525
Capital expenditures(237,404)(211,347)
Proceeds from disposal of property, plant and equipment43,61939,179
Investments in partnerships and joint ventures(7,562)(8,235)
Proceeds from the sale of assets11,016 
Acquisitions(15,300) 
Other items5,743(2,576)
Cash (utilized) provided by investing activities(104,662)232,107
CASH FLOWS FROM FINANCING ACTIVITIES  
Repurchase of common stock(599,891)(17,071)
Dividends paid(66,351)(67,576)
Proceeds from issuance of Senior Notes495,595 
Debt issuance costs(4,059) 
Settlement of treasury rate lock agreements(16,778) 
Repayment of convertible debt(73,039)(10,567)
Distributions paid to noncontrolling interests(72,270)(55,562)
Capital contribution by joint venture partner22,5891,000
Repayment of corporate-owned life insurance loans (32,163)
Taxes paid on vested restricted stock(18,690)(6,877)
Stock options exercised25,3432,307
Stock plans tax benefit12,319606
Other items(4,236)(3,191)
Cash utilized by financing activities(299,468)(189,094)
Effect of exchange rate changes on cash(55,757)36,688
Increase in cash and cash equivalents251,292290,117
Cash and cash equivalents at beginning of period2,134,9971,687,028
Cash and cash equivalents at end of period$ 2,386,289$ 1,977,145